Center for Drug Evaluation & Research Deputy Director for Clinical Science Robert Temple has not yet participated in a “virtual” advisory committee meeting hosted by the US Food & Drug Administration, but he is concerned about the impact of the format.
“As a general matter, it matters when people are in the room,” Temple said during a Prevision Policy/Friends of Cancer Research event recorded on 20 October. “They look at each...